C1q deposition in the renal allograft: A report of 24 cases

Modern Pathology

Volumn 23, Issue 8, 2010, Pages 1080-1088

  Said, Samar M ^a   Cornell, Lynn D ^a   Valeri, Anthony M ^b   Sethi, Sanjeev ^a   Fidler, Mary E ^a   Cosio, Fernando G ^a   Nasr, Samih H ^a  

^a MAYO CLINIC   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

C1q nephropathy; de novo glomerular disease; FSGS; mesangial hypercellularity; proteinuria; transplant

Indexed keywords

COMPLEMENT COMPONENT C1Q; CREATININE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HEMATURIA; HUMAN; HYPOALBUMINEMIA; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MALE; MESANGIUM; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BIOPSY; COMPLEMENT C1Q; FEMALE; GLOMERULAR MESANGIUM; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; POSTOPERATIVE COMPLICATIONS; PROTEINURIA; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 77955173975     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.92     Document Type: Article

References (17)

1. Jones E, Magil A. Nonsystemic mesangiopathic glo-merulonephritis with 'full house' immunofluores-cence. Pathological and clinical observation in five patients. Am J Clin Pathol 1982;78:29-34.
2. Jennette JC, Hipp CG. C1q nephropathy: a distinct pathologic entity usually causing nephrotic syndrome. Am J Kidney Dis 1985;6:103-110.
3. Iskandar SS, Browning MC, Lorentz WB. C1q nephro-pathy: a pediatric clinicopathologic study. Am J Kidney Dis 1991;18:459-465.
4. Markowitz GS, Schwimmer JA, Stokes MB, et al. C1q nephropathy: a variant of focal segmental glomerulo-sclerosis. Kidney Int 2003;64:1232-1240.
5. Wong CS, Fink CA, Baechle J, et al. C1q nephropathy and minimal change nephrotic syndrome. Pediatr Nephrol 2009;24:761-767.
6. Vizjak A, Ferluga D, Rozic M, et al. Pathology, clinical presentations, and outcomes of C1q nephropathy. J Am Soc Nephrol 2008;19:2237-2244.
7. Hisano S, Fukuma Y, Segawa Y, et al. Clinicopatholo-gic correlation and outcome of C1q nephropathy. Clin J Am Soc Nephrol 2008;3:1637-1643.
8. Isaac J, Shihab FS. De novo C1q nephropathy in the renal allograft of a kidney pancreas transplant recipient: BK virus-induced nephropathy? Nephron 2002;92: 431-436.
9. Guy M, Borzomato JK, Newall RG, et al. Protein and albumin-to-creatinine ratios in random urines accurately predict 24h protein and albumin loss in patients with kidney disease. Ann Clin Biochem 2009;46: 468-476.
10. Fukuma Y, Hisano S, Segawa Y, et al. Clinicopatholo-gic correlation of C1q nephropathy in children. Am J Kidney Dis 2006;47:412-418.
11. Truong L, Gelfand J, D'Agati V, et al. De novo membranous glomerulonephropathy in renal allo-grafts: a report of ten cases and review of the literature. Am J Kidney Dis 1989;14:131-144.
12. Antignac C, Hinglais N, Gubler MC, et al. De novo membranous glomerulonephritis in renal allografts in children. Clin Nephrol 1988;30:1-7.
13. Amer H, Fidler ME, Myslak M, et al. Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 2007;7:2748-2756.
14. Ponticelli C, Traversi L, Feliciani A, et al. Kidney transplantation in patients with IgA mesangial glomer-ulonephritis. Kidney Int 2001;60:1948-1954.
15. Amer H, Cosio FG. Significance and management of proteinuria in kidney transplant recipients. J Am Soc Nephrol 2009;20:2490-2492.
16. Snyder JJ, Israni AK, Peng Y, et al. Rates of first infection following kidney transplant in the United States. Kidney Int 2009;75:317-326.
17. Kersnik Levart T, Kenda RB, Avgustin Cavić M, et al. C1Q nephropathy in children. Pediatr Nephrol 2005; 20:1756-1761.